EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 4th, 2017 • Pacira Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This Executive Employment Agreement (the “Agreement”), is entered into as of April 11, 2016 (the “Effective Date”), by and between Pacira Pharmaceuticals, Inc., a California corporation (the “Company”), and Robert Weiland (the “Executive”).
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH “[**]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION.Co-Promotion Agreement • May 4th, 2017 • Pacira Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Co-Promotion Agreement (this “Agreement”) is entered into this 24th day of January, 2017 (the “Effective Date”), by and between Pacira Pharmaceuticals Inc., a Delaware corporation (“Pacira”), and DePuy Synthes Sales, Inc., a Massachusetts corporation (“DePuy Synthes”). Each of Pacira and DePuy Synthes is referred to herein, individually, as a “Party” and collectively, as the “Parties.”
